$4550
MARKET OVERVIEW will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
In many underdeveloped nations, acute diarrheal illnesses rank among the most common causes of infant and neonatal mortality. Additionally, people fromall age groups can be affected and most severe cases of, dehydration from diarrhea can be treated easily, affordably, and simply by giving patients a good glucose-electrolyte solution called oral rehydration salts (ORS) solution orally. The World Health Organisation (WHO) and the United Nations Children's Fund advise using oral rehydration therapy (ORS), a glucose-based salt solution, to treat or prevent diarrhea-related dehydration. This solution has an osmolarity of 245 mOsm/l and includes 75 mmol/l of glucose and 75 mEq/l of sodium. However, ORS can cause side effects, including vomiting, high blood potassium, and high blood salt levels.
Since 2003, WHO and UNICEF have encouraged using a new ORS formulation that is more effective than the previous formulation. The WHO Expert Committee on specifications forpharmaceutical preparations approved a revised monograph for ORS that details this new formulation at its meeting in October 2005 to be included in the fourth edition of The International Pharmacopoeia. Furthermore, commercially available ORS products comprise sachets, ice cubes, beverages, and effervescent tablets for solution preparationthat are frequently offered and have a wide range of flavours.
MARKET SCOPE
The "Global oral rehydration salts market analysis to 2030" is a specialized and in-depth study of the pharmaceutical industry with a special focus on global market trend analysis. The report aims to provide an overview of the oral rehydration salts market with detailed market segmentation by product sales, dosage form, age group, indication, distribution channel, and geography. The report provides key statistics on the market status of the leading oral rehydration salts market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The oral rehydration salts market is segmented based on product sales, dosage form, age group, indication, distribution channel, and region. Based on product sales the global oral rehydration salts market is bifurcated into otc products and prescriptions. Based on dasage form, the oral rehydration salts market is bifurcated into a powder and liquid tablets. Based on age group, oral rehydration salts market is classified into infants, children and adults. By indication, market is segregated into diarrhea, gastroenteritis, electrolyte imbalance and others. The oral rehydration salts market is segmented by distribution channel into hospital pharmacies, retail pharmacies and online pharmacies.
MARKET DYNAMICS
Drivers-
The increasing cases of diahrea on global level favorably impact the oral rehydration salts market. According to WHO, over 1.7 million people experience diarrhea worldwide, and 760,000 children are expected to die from diarrhea associated dehydration. Regardless of the etiology or age range impacted, WHO and UNICEF have ecouranged the use of new ORS formulation for the past three decades for prevention and treatment of dehydration from diarrhea. Due to an increase in severe diarrhoea cases in childrens under age of 5 years require ORS solutions which will increase the demand for oral rehydration salts. The ORS demand is estimated by the help of national program that uses epidemiological statistics. To provide nations with a safe and reliable programme supply, UNICEF has found and is marketing high-quality co-packaged ORS and zinc, that is helping governments increase the use of these substances.
Furthermore, the pharmaceutical and healthcare industries are expanding quickly due to technological advancements, rising healthcare spending, and improved healthcare infrastructure and systems. Around the world, several clinics, ambulatory surgical centres, and hospitals are implementing various awareness programs for dehydration which will drive the oral rehydration salts market.. Global oral rehydration salts (ORS) market revenue growth is largely attributed to factors like rising chronic disease prevalence, quick advancements in healthcare and medicine, and rising public and private funding. Additionally, throughout the forecast period, rising investments in research & development activities, and rising focus on medication development are anticipated to propel global oral rehydration salts market growth.
REGIONAL FRAMEWORK
North America is expected to hold the major market share in oral rehydration salts market in 2022 owing to the rising incidences of diarrheal disease in the region. Increase in the number of health-conscious consumers in North America, growing emphasis on introducing oral electrolyte solutions with innovative packaging, and increase in sports activities, are factors expected to fuel the growth of the North America oral electrolyte solutions market. Sales growth in this industry will probably be aided by expanding the distribution network for these beverages, including supermarkets, convenience stores, and e-commerce websites. Oral electrolyte solution sales are rising due to people's changing lifestyles increasing their discretionary income and enabling them to spend more on ready-to-consume goods. Additionally, the changing lifestyles of consumers due to improved health and awareness are providing opportunities for the market growth, and manufacturers anticipate that sales of oral electrolyte solutions would rise during the projection period.
During the projection period, Asia Pacific is anticipated to grow significantly in market share for oral rehydration salts (ORS). The oral rehydration salt (ORS) market growth is driven by increased awareness of childhood malnutrition, an increase in the number of non-government organisations working to promote child health, and significant investments in children's healthcare programmes in nations like India. According to UNICEF, the prevalence of malnutrition is still extremely high, and 50% of all fatalities in children under the age of 5 yeras are related to undernutrition. The UNICEF estimates that in March 2019, 149.0 million children had stunted growth and nearly 49.0 million were underweight. Furthermore, it is envisaged that government and non-profit organizations' involvement in supplying oral electrolyte solutions will drive the oral rehydration salts market growth.
Have a question?
Speak to Analyst
The report covers key oral rehydration salts market developments, such as organic and inorganic growth strategies. Various companies such as Abbott, AstraZeneca, BoehringerIngelheim, Eli Lilly & Company, Mylan N.V., Pfizer, Depomed Inc., Endo International Plc., GlaxoSmithKline Plc., Johnson & Johnson, Merck & Co. Inc., Novartis AG, Purdue Pharma L.P., Teva Pharmaceutical Industries and among others are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, partnerships & collaborations. These activities have paved the way for the expansion of business and the customer base of market players. The market players from the oral rehydration salts market are anticipated to have lucrative growth opportunities with the rising demand for oral rehydration salts in the global market.
Key Developments in Global Oral Rehydration Salts Market
- In January 2022, The FDC brand Electral Z+ (ORS+Zinc Solution) and UFlex-Asepto, India's first aseptic liquid packaging producer, are collaborating on ready-to-drink (RTD), over-the-counter goods. Halewood Laboratories Private is the manufacturer of the formulation.
- In June 2022, Otsuka Pharmaceutical Factory launched OS-1 Apple Flavor 300 mL and 500 mL to the oral rehydration solution OS-1 series.
- In June 2021, Over 93 million zinc tablets and more than 30 million oral rehydration salt sachets were delivered by UNICEF worldwide, and the organization seeks to increase consumer access to co-packaged goods.
The report includes key companies' profiles, SWOT analysis, and oral rehydration salts market size and strategies. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information for the last three years, and key development in the past five years.
The Insight Partner’s dedicated research and analysis team comprises experienced professionals with advanced statistical expertise and offers various customization options in the current study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
The List of Companies
1. ZYDUS CADILA HEALTHCARE LTD.
2. LUPIN
3. INTAS PHARMACEUTICAL
4. DR. REDDYS
5. MANKIND PHARMA
6. CIPLA LIMITED
7. OTSUKA PHARMACEUTICAL CO., LTD.
8. RECKITT BENCKISER GROUP PLC
9. SHEREYA LIFE SCIENCES PVT. LTD.
10. WALLACE PHARMA
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports

Sep 2023
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography

Sep 2023
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography

Sep 2023
Drug Delivery Market
Forecast to 2028 - Global Analysis By Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug Delivery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End User (Hospitals and Clinics, Home Care Settings, and Other End User)

Sep 2023
Enteral and Parenteral Medical Nutrition Market
Forecast to 2028 - Global Analysis by Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer's Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole–Source), Form (Liquid, Powder, and Semi–Solid), Product Type (General and Disease–Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18–60 Years, 3–18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)

Sep 2023
CIN & HR-HPV Treatment Market
Forecast to 2028 - Global Analysis By Disease Type (Cervical Intraepithelial Neoplasia 1, Cervical Intraepithelial Neoplasia 2, and Cervical Intraepithelial Neoplasia 3), Strain Type (HPV 16, HPV 18, and Others), Offering (Diagnostic Method and Treatment), Product Type (Kits & Reagents, Instruments, and Services), and End User (Hospitals & Clinics, Diagnostic Laboratories, Specialized Clinical Laboratories, and Others)

Sep 2023
Pharmaceutical Fluid Handling Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Offering (Equipment & Solutions and Services), Tubing (Thermoplastic Elastomers, Polyvinyl Chloride, and Silicone), Application (Fluid Handling & Management, Fluid Preparation, Integration & Automation, Buffer Management, and Others), Usage (Cough Syrup, Intravenous Product, Complex Active Pharmaceutical Ingredients, and Others), and End User (Biotechnology Companies, Pharmaceutical & Medical Companies, and Others)

Sep 2023
Enteral Medical Nutrition Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Indication (Respiratory Disorders, Cancer, Post COVID-19, Gastrointestinal Disorders, Liver Failure, and Others), Nutrition Type (Supplemental and Sole-Source), Form (Powder, Liquid, and Semi-Solid), Product (Standard Protein Diet, High Protein Diet, Fruit Juice Based Oral Nutritional Supplement, and Others), Distribution Channel (Hospital Pharmacies, Retail Stores, and Others), and Age Group [Child (Till 18 Years) and Adults (18+years)]

Sep 2023
Glycomic Therapeutics Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Class (Isolated and Synthetic), Structures [Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins & Heparin Based Glycans, Targeting Glycosphingolipids, and Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), and Mode of Action [Inhibits Neuraminidase; Inhibits Heparanase and Selectins and Blocks Interactions Between Growth Factors and Heparan Sulfate; Erythropoietin & Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 & 3; Beta & Gamma Interferons; and Others]